Privium Fund Management B.V.
Latest statistics and disclosures from Privium Fund Management B.V.'s latest quarterly 13F-HR filing:
- Top 5 stock holdings are TSLA, SHOP, SPOT, PLTR, AMZN, and represent 45.51% of Privium Fund Management B.V.'s stock portfolio.
- Added to shares of these 10 stocks: ESPR (+$9.0M), BMRN (+$5.2M), DNLI, ALNY, IONS, IREN, QURE, MOH, VRTX, AMZN.
- Started 7 new stock positions in ALNY, BMRN, PAAS, BTG, DNLI, MOH, ESPR.
- Reduced shares in these 10 stocks: BIIB (-$5.4M), , TSLA, ARWR, VZLA, SLB, MRNA, BNTX, SPOT, FDMT.
- Sold out of its positions in MRK, VZLA, NOMD, VAL.
- Privium Fund Management B.V. was a net buyer of stock by $16M.
- Privium Fund Management B.V. has $480M in assets under management (AUM), dropping by -11.57%.
- Central Index Key (CIK): 0001795097
Tip: Access up to 7 years of quarterly data
Positions held by Privium Fund Management B.V. consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Privium Fund Management B.V.
Privium Fund Management B.V. holds 60 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Tesla Motors (TSLA) | 17.2 | $83M | -2% | 222k | 371.75 |
|
| Shopify Cl A Sub Vtg Shs (SHOP) | 10.1 | $48M | 407k | 118.62 |
|
|
| Spotify Technology S A SHS (SPOT) | 6.8 | $33M | 67k | 484.91 |
|
|
| Palantir Technologies Cl A (PLTR) | 6.1 | $29M | 200k | 146.28 |
|
|
| Amazon (AMZN) | 5.4 | $26M | +3% | 125k | 208.27 |
|
| Arrowhead Pharmaceuticals (ARWR) | 4.8 | $23M | -7% | 367k | 62.70 |
|
| Ionis Pharmaceuticals (IONS) | 4.5 | $22M | +20% | 290k | 75.09 |
|
| Lemonade (LMND) | 3.3 | $16M | +2% | 255k | 62.68 |
|
| NVIDIA Corporation (NVDA) | 2.9 | $14M | 81k | 174.40 |
|
|
| Coinbase Global Com Cl A (COIN) | 2.9 | $14M | 79k | 174.61 |
|
|
| Advanced Micro Devices (AMD) | 2.6 | $13M | +3% | 62k | 203.43 |
|
| Ast Spacemobile Com Cl A (ASTS) | 2.5 | $12M | 145k | 82.87 |
|
|
| Sea Sponsord Ads (SE) | 2.4 | $11M | 138k | 82.81 |
|
|
| Iren Ordinary Shares (IREN) | 2.3 | $11M | +14% | 320k | 34.28 |
|
| Axsome Therapeutics (AXSM) | 2.1 | $9.9M | +3% | 59k | 169.02 |
|
| Esperion Therapeutics (ESPR) | 1.9 | $9.0M | NEW | 3.3M | 2.74 |
|
| Proqr Thrapeutics N V Shs Euro (PRQR) | 1.8 | $8.9M | +2% | 5.5M | 1.62 |
|
| Biogen Idec (BIIB) | 1.7 | $8.0M | -40% | 44k | 183.33 |
|
| Uniqure Nv SHS (QURE) | 1.7 | $8.0M | +16% | 487k | 16.35 |
|
| Ultragenyx Pharmaceutical (RARE) | 1.6 | $7.6M | +2% | 365k | 20.95 |
|
| Arcutis Biotherapeutics (ARQT) | 1.6 | $7.6M | +4% | 321k | 23.56 |
|
| BioMarin Pharmaceutical (BMRN) | 1.1 | $5.2M | NEW | 92k | 56.49 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.1 | $5.1M | +21% | 11k | 446.54 |
|
| Denali Therapeutics (DNLI) | 1.0 | $4.9M | NEW | 255k | 19.20 |
|
| Urogen Pharma (URGN) | 0.9 | $4.3M | +10% | 238k | 17.98 |
|
| Alnylam Pharmaceuticals (ALNY) | 0.8 | $4.0M | NEW | 12k | 330.87 |
|
| Miragen Therapeutics (VRDN) | 0.7 | $3.4M | 174k | 19.56 |
|
|
| Krystal Biotech (KRYS) | 0.6 | $2.9M | -8% | 11k | 258.32 |
|
| Ambev Sa Sponsored Adr (ABEV) | 0.6 | $2.8M | -10% | 949k | 2.92 |
|
| Zai Lab Adr (ZLAB) | 0.5 | $2.5M | 132k | 18.81 |
|
|
| Biontech Se Sponsored Ads (BNTX) | 0.5 | $2.4M | -18% | 27k | 88.88 |
|
| Engene Holdings (ENGN) | 0.5 | $2.4M | 352k | 6.81 |
|
|
| Crispr Therapeutics Namen Akt (CRSP) | 0.4 | $2.0M | 43k | 47.57 |
|
|
| Meiragtx Holdings (MGTX) | 0.4 | $1.8M | +6% | 212k | 8.66 |
|
| Wave Life Sciences SHS (WVE) | 0.4 | $1.7M | +24% | 241k | 7.25 |
|
| Stoke Therapeutics (STOK) | 0.3 | $1.6M | -9% | 50k | 32.56 |
|
| 4d Molecular Therapeutics In (FDMT) | 0.3 | $1.6M | -18% | 170k | 9.31 |
|
| Beam Therapeutics (BEAM) | 0.3 | $1.5M | -10% | 64k | 23.83 |
|
| Moderna (MRNA) | 0.3 | $1.5M | -39% | 30k | 50.80 |
|
| Pfizer (PFE) | 0.3 | $1.5M | +39% | 53k | 28.08 |
|
| Lexeo Therapeutics (LXEO) | 0.2 | $1.2M | +6% | 205k | 5.74 |
|
| Cartesian Therapeutics Com New (RNAC) | 0.2 | $1.1M | +3% | 179k | 6.15 |
|
| Molina Healthcare (MOH) | 0.2 | $1.1M | NEW | 8.1k | 133.30 |
|
| Sarepta Therapeutics (SRPT) | 0.2 | $1.0M | +6% | 46k | 21.76 |
|
| SLB Com Stk (SLB) | 0.2 | $948k | -52% | 19k | 51.39 |
|
| Rocket Pharmaceuticals (RCKT) | 0.2 | $867k | +42% | 242k | 3.58 |
|
| Hims & Hers Health Com Cl A (HIMS) | 0.2 | $830k | 40k | 20.76 |
|
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.2 | $813k | +10% | 182k | 4.47 |
|
| Nov (NOV) | 0.2 | $791k | -20% | 42k | 18.81 |
|
| Transocean Registered Shs (RIG) | 0.1 | $707k | -23% | 107k | 6.63 |
|
| Seabridge Gold (SA) | 0.1 | $704k | +4% | 25k | 28.34 |
|
| Sandridge Energy Com New (SD) | 0.1 | $633k | 39k | 16.31 |
|
|
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $502k | +11% | 363k | 1.38 |
|
| Fate Therapeutics (FATE) | 0.1 | $497k | +12% | 414k | 1.20 |
|
| Voyager Therapeutics (VYGR) | 0.1 | $463k | +26% | 120k | 3.86 |
|
| Tidewater (TDW) | 0.1 | $458k | 5.5k | 83.55 |
|
|
| B2gold Corp (BTG) | 0.1 | $437k | NEW | 97k | 4.53 |
|
| Noble Corp Ord Shs A (NE) | 0.1 | $336k | -36% | 6.8k | 49.07 |
|
| Pan American Silver Corp Can (PAAS) | 0.0 | $213k | NEW | 3.9k | 54.63 |
|
| Sprott Fds Tr Uranium Miners E (URNM) | 0.0 | $209k | -38% | 3.3k | 63.15 |
|
Past Filings by Privium Fund Management B.V.
SEC 13F filings are viewable for Privium Fund Management B.V. going back to 2021
- Privium Fund Management B.V. 2026 Q1 filed May 5, 2026
- Privium Fund Management B.V. 2025 Q4 filed Feb. 3, 2026
- Privium Fund Management B.V. 2025 Q3 filed Nov. 4, 2025
- Privium Fund Management B.V. 2025 Q2 filed July 30, 2025
- Privium Fund Management B.V. 2025 Q1 filed May 9, 2025
- Privium Fund Management B.V. 2024 Q4 filed Feb. 11, 2025
- Privium Fund Management B.V. 2024 Q3 filed Nov. 1, 2024
- Privium Fund Management B.V. 2024 Q2 filed Aug. 1, 2024
- Privium Fund Management B.V. 2024 Q1 filed April 30, 2024
- Privium Fund Management B.V. 2023 Q4 restated filed Feb. 26, 2024
- Privium Fund Management B.V. 2023 Q3 filed Nov. 6, 2023
- Privium Fund Management B.V. 2023 Q2 filed July 26, 2023
- Privium Fund Management B.V. 2023 Q2 restated filed July 26, 2023
- Privium Fund Management B.V. 2023 Q1 filed May 3, 2023
- Privium Fund Management B.V. 2022 Q4 filed Feb. 3, 2023
- Privium Fund Management B.V. 2022 Q3 filed Nov. 3, 2022